Longevity Pfizer’s monthly obesity drug shows promise, spooks investorsBy adminFebruary 8, 20260 Once-a-month shot delivers meaningful weight loss, but Wall Street remains uneasy about competition, tolerability and timing. Pfizer’s obesity moment finally…
DNA & Genetics Pfizer’s Deal with Trump Pays off for InvestorsBy adminOctober 6, 20250 By stepping out as the first biopharma to win a three-year “grace period” exemption from President Donald Trump’s earlier-announced plans…
